When to Choose MRN Over Ultrasound - Report - MDSpire

When to Choose MRN Over Ultrasound

Proximal location, multi-nerve involvement, and multi-region extent favor MRN; ultrasound retains value for dynamic assessment and metal artifact–limited cases.

  • By

  • Andrea Surnit

  • May 14, 2026

  • 4 min

Share

Clinical Report: When to Choose MRN Over Ultrasound

Overview

Magnetic resonance neurography (MRN) demonstrates superior diagnostic value compared to high-resolution ultrasound (HRUS) in detecting upper-extremity peripheral neuropathies, particularly in complex cases, as evidenced by specific metrics such as odds ratios. This study highlights the importance of lesion topography in determining the choice of imaging modality.

Background

Upper-extremity peripheral neuropathies are common and can significantly impact patient quality of life. Accurate diagnosis is crucial for effective management, and advanced imaging techniques like MRN and HRUS play a vital role in this process. Understanding when to utilize each modality can enhance diagnostic accuracy and patient outcomes.

Data Highlights

FindingMRNHRUS
Concordant findings60%60%
Discordant findings40%40%
Cases with additional diagnostic value261 (94.9%)14 (5.1%)
Odds of added value (proximal lesions)5.72 (95% CI: 3.42–9.56)N/A
Odds of added value (multi-nerve disease)1.65 (95% CI: 1.03–2.63)N/A

Key Findings

  • MRN provided additional diagnostic value in 94.9% of cases compared to HRUS.
  • Proximal-only lesions had 5.72 times the odds of added diagnostic value from MRN.
  • Multi-anatomical-region involvement favored MRN with an odds ratio of 1.81.
  • Clinical symptoms were less predictive of MRN value than lesion anatomy.
  • HRUS was primarily useful for superficial focal lesions and dynamic assessments, but its effectiveness is highly operator-dependent.

Clinical Implications

Clinicians should consider MRN as the preferred imaging modality for complex upper-extremity neuropathies, especially when proximal lesions or multi-nerve involvement is suspected. HRUS may serve as a complementary tool in specific scenarios, particularly for superficial lesions, but its performance can vary significantly based on the operator's skill.

Conclusion

The findings support a tailored imaging approach, favoring MRN in complex cases while recognizing the utility of HRUS in certain contexts. Further studies are needed to validate these results across broader patient populations and different clinical settings.

Related Resources & Content

  1. Brunnée M., European Radiology, 2026 -- High-resolution ultrasound vs. MR neurography in upper extremity neuropathies: exploratory analysis of perceived additional diagnostic value in routine clinical practice
  2. The ASCO Post, 2025 -- Microultrasound- vs MRI-Guided Biopsy for Prostate Cancer Diagnosis
  3. European Radiology — Assessing Membranous Urethral Length via Preoperative MRI to Forecast Incontinence Risk Following Radical Prostatectomy: A Review of Literature and Proposal for Standardized Measurement Techniques
  4. European Radiology — Choosing wisely in neuroradiology: evaluating CT and MR utilization trends in Europe
  5. ACR Appropriateness Criteria
  6. Diagnostic Imaging on Ultrasound vs MRI for Peripheral Nerve Disorders
  7. Contrast-enhanced magnetic resonance neurography for diagnosing brachial plexopathy: improved visualization and additional imaging features | Scientific Reports

Original Source(s)

When to Choose MRN Over Ultrasound

  • by Andrea Surnit

  • May 14, 2026

Related Content

Whole-Body MRI: Evidence Gap Widens

Two radiologists argue the for-profit scan industry has outrun the evidence — and the math warrants scrutiny.

Ultrasound Attenuation Imaging Tracks Hepatic Steatosis

Attenuation imaging increased with visually graded steatosis severity in pediatric patients, but findings were not validated against MRI-PDFF or biopsy.

AI Model May Help Decipher Malignant, Benign Breast Lesions on MRI

Model matches deep-learning accuracy and helps physicians reclassify benign breast lesions.